Chief Commercial Officer
Ryan Bernhardt is the Chief Commercial Officer for Biosero where he leads Business Development opportunities through strategic partnerships, collaborations, and commercial agreements to increase diverse market penetration for Biosero’s industry-leading Green Button Go automation scheduling software suite. In this role, Ryan also oversees Biosero’s productization roadmap and strategic focus as it relates to Sales, Marketing, Customer Success, Applications, and Business Development. Prior to joining Biosero, Ryan Bernhardt, spent the last six and half years at Eli Lilly and Company as the Global Discovery Automation Research and Technologies Group Leader, leading a team of automation engineers and scientists in the design, implementation, and operation of a variety of innovative automation initiatives across Research and Development Laboratories. During his time at Lilly, Ryan was the Automation Architect and Integration Leader for the Lilly Life Sciences Studio (L2S2); a state-of-the-art, fully automated Drug Discovery Platform located at Lilly’s Biotechnology Center in La Jolla, CA. Ryan received Lilly’s Top 100 Innovator Award for his track-based, modular design of L2S2 which incorporates a multi-level scheduling software infrastructure. This physical and digital automation architecture has influenced the design of many other automated platforms and products across the external Life Science and Lab Automation communities. Among many other projects, Ryan led his team in the design and implementation of one of the world’s first fully automated Covid-19 Diagnostic Testing processes for Lilly’s Clinical Diagnostic Lab at the onset of the pandemic in early March 2020. Prior to joining Lilly, Ryan held a few positions at Hamilton Robotics, including his role as the Global Business Unit Leader of Emerging Automation Markets.